COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,243 Articles (22,733 medRxiv, 8,510 bioRxiv)

Most recent first Previous |  Page 299: Articles 2981-2990  | Next

Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality
CHRISTIAN, N., ZHOU, X., RADHAKRISHNAN, R.
10.1101/2023.11.24.23298995 — Posted: 2023-11-27
The Antiviral Mechanism of Action of Molnupiravir in Humans with COVID-19
Sheahan, T. P., Stevens, L. J., Narowski, T. M., Krajewski, T. J., Lee, C., Mollan, K. R., Gribble, J., Moreria, F. R., Castillo, I. N., Cuadra, E., Alabanza, P., James Loftis, A., Coombs, R. W., Goecker, E. A., Greninger, A. L., Chappell, J. D., Brown, A. J., Won, J., Lipansky, F., Holman, W., Szewczyk, L. J., Baric, R. S., Painter, W. P., Eron, J. J., Premkumar, L., Denison, M. R., Fischer, W. A.
10.1101/2023.11.21.23298766 — Posted: 2023-11-27
Variant- and Vaccination-Specific Alternative Splicing Profiles in SARS-CoV-2 Infections
Lee, S.-G., Furth, P., Hennighausen, L., Lee, H. K.
10.1101/2023.11.24.568603 — Posted: 2023-11-27
Evolution-guided large language model is a predictor of virus mutation trends
Nie, Z., Liu, X., Chen, J., Wang, Z., Liu, Y., Si, H., Dong, T., Xu, F., Song, G., Wang, Y., Zhou, P., Gao, W., Tian, Y.
10.1101/2023.11.27.568815 — Posted: 2023-11-27
Modulation of human kinase activity through direct interaction with SARS-CoV-2 proteins
Halwachs, B., Moesslacher, C. S., Kohlmayr, J. M., Fasching, S., Masser, S., Choteau, S. A., Zanzoni, A., Stelzl, U.
10.1101/2023.11.27.568816 — Posted: 2023-11-27
Identification of the host reservoir of SARS-CoV-2 and determining when it spilled over into humans
Pamjula, V., Strachan, N. J. C., Perez-Reche, F. J.
10.1101/2023.11.25.568670 — Posted: 2023-11-27
Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2 derived RBD antigen
Ramos-Duarte, V. A., Orlowski, A., Jaquenod de Giusti, C., Corigliano, M. G., Legarralde, A., Mendoza-Morales, L. F., Atela, A., Sanchez, M. A., Sander, V. A., Angel, S. O., Clemente, M.
10.1101/2023.11.25.568642 — Posted: 2023-11-27
The antiviral potential of the antiandrogen enzalutamide and the viral-androgen interplay in seasonal coronaviruses
Ogunjinmi, O. D., Abdullahi, T., Somji, R.-A., Bevan, C. L., Barclay, W. S., Temperton, N. J., Brooke, G. N., Giotis, E. S.
10.1101/2023.11.25.568685 — Posted: 2023-11-27
Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection.
Lercher, A., Cheong, J.-G., Jiang, C., Hoffmann, H.-H., Ashbrook, A. W., Yin, Y. S., Quirk, C., DeGrace, E. J., Chiriboga, L., Rosenberg, B. R., Josefowicz, S. Z., Rice, C. M.
10.1101/2023.11.24.568354 — Posted: 2023-11-27
Isogenic iPSC-derived proximal and distal lung-on-chip models: Tissue- and virus-specific immune responses in human lungs
Yadav, S., Fujimoto, K., Takenaga, T., Takahashi, S., Muramoto, Y., Mikawa, R., Noda, T., Gotoh, S., Yokokawa, R.
10.1101/2023.11.24.568532 — Posted: 2023-11-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).